Valbiotis SAS (PA:ALVAL) — Stock Price

€0.81 EUR
▲ 1.24% today

Valbiotis SAS (PA:ALVAL) is currently trading at €0.81 EUR, up 1.24% today. Over the past 52 weeks, shares have ranged between €0.55 and €1.21. This page tracks Valbiotis SAS's live share price on the PA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market cap of Valbiotis SAS.

Valbiotis SAS (ALVAL) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Valbiotis SAS's daily closing share price and trading volume on the PA exchange over the past year, giving a clear view of recent price momentum and liquidity.

Valbiotis SAS Income Statement — Revenue, Profit & Earnings by Year

Valbiotis SAS's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue €905.00K €175.00K €4.73 Million €785.00K €298.00K
Cost of Revenue €2.07 Million €2.62 Million €2.04 Million €18.00K €16.00K
Gross Profit €-1.17 Million €-2.44 Million €2.69 Million €767.00K €282.00K
Research & Development €921.00K €4.33 Million €7.15 Million €9.10 Million €7.03 Million
SG&A €7.18 Million €3.73 Million €2.16 Million €688.00K €360.00K
Total Operating Expenses €8.33 Million €7.98 Million €9.87 Million €12.79 Million €8.76 Million
Operating Income €-9.49 Million €-10.42 Million €-7.16 Million €-14.05 Million €-10.87 Million
EBITDA €-9.49 Million €-9.17 Million €-6.41 Million €-11.13 Million €-9.14 Million
EBIT €-9.76 Million €-7.15 Million €-11.99 Million €-10.08 Million
Interest Expense €156.00K €230.00K €221.00K €287.00K €348.00K
Income Before Tax €-9.42 Million €-9.99 Million €-9.40 Million €-14.20 Million €-10.43 Million
Income Tax Expense €2.00K €34.00K €-2.03 Million €-1.89 Million €-1.75 Million
Net Income €-9.42 Million €-10.03 Million €-7.37 Million €-12.31 Million €-8.68 Million

Valbiotis SAS Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Valbiotis SAS's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets €14.39 Million €19.61 Million €33.31 Million €27.17 Million €28.48 Million
Total Current Assets €11.92 Million €16.87 Million €30.65 Million €24.30 Million €25.19 Million
Cash & Equivalents €6.57 Million €7.91 Million €2.50 Million €492.00K €541.00K
Short-term Investments €63.00K €49.00K
Net Receivables €255.00K €2.50 Million €4.24 Million €2.78 Million €2.81 Million
Inventory €2.46 Million €2.09 Million €1.00 Million €529.00K €421.00K
Property, Plant & Equipment €1.18 Million €1.47 Million €1.41 Million €1.82 Million €2.22 Million
Goodwill
Total Liabilities €7.43 Million €9.24 Million €13.71 Million €13.86 Million €14.25 Million
Total Current Liabilities €4.18 Million €5.55 Million €8.77 Million €8.11 Million €7.94 Million
Long-term Debt €2.21 Million €2.52 Million €3.90 Million €4.35 Million €4.60 Million
Net Debt €-3.59 Million €-5.86 Million €-18.14 Million €-13.65 Million €-14.23 Million
Total Stockholder Equity €6.96 Million €10.37 Million €19.60 Million €13.31 Million €14.23 Million
Retained Earnings €-9.42 Million €-10.03 Million €-7.37 Million €-12.31 Million €-8.68 Million

Valbiotis SAS Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Valbiotis SAS generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow €-8.04 Million €-11.54 Million €-8.06 Million €-9.19 Million €-7.16 Million
Capital Expenditures €151.00K €261.00K €263.00K €288.00K €421.00K
Free Cash Flow €-8.19 Million €-11.80 Million €-8.30 Million €-9.48 Million €-7.58 Million
Investing Cash Flow €-77.00K €-61.00K €-250.00K €-197.00K €-7.00K
Financing Cash Flow €5.21 Million €-1.84 Million €12.49 Million €8.40 Million €14.40 Million
Dividends Paid
Stock-Based Compensation €300.00K €631.00K €598.00K €2.34 Million €1.45 Million
Depreciation €296.00K €587.00K €689.00K €802.00K €941.00K
Change in Cash €-2.90 Million €-13.44 Million €4.19 Million €-991.00K €7.23 Million

Valbiotis SAS Earnings History — EPS Actual vs. Analyst Estimates

Track Valbiotis SAS's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Mar 02, 2026
Oct 13, 2025 -0.29 0.00
Apr 25, 2025
Mar 03, 2025 -0.21 0.00
Mar 15, 2023 -0.69
Sep 15, 2022 -0.52
Mar 15, 2022 -0.54
Sep 30, 2021 -0.40